Anti-MN1

Anti-MN1
Item number Size Datasheet Manual SDS Delivery time Quantity Price
ELK-ES2807.50 50 µl - -

10 - 15 business days*

173.00€
ELK-ES2807.100 100 µl - -

10 - 15 business days*

290.00€
 
Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation... more
Product information "Anti-MN1"
Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis. [provided by RefSeq, Jul 2008], Protein function: Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull. May play a role in tumor suppression (Probable). [The UniProt Consortium] Recommended dilutions: WB 1:500-2000,IHC-p 1:50-300, ELISA 2000-20000. Cellular localization: Nucleus .
Keywords: Anti-MN1, Anti-Transcriptional activator MN1, Anti-Probable tumor suppressor protein MN1, MN1 rabbit pAb
Supplier: ELK Biotechnology
Supplier-Nr: ES2807

Properties

Application: WB, ELISA, IHC
Antibody Type: Polyclonal
Conjugate: No
Host: Rabbit
Species reactivity: human, rat, mouse,
Immunogen: The antiserum was produced against synthesized peptide derived from human MN1. AA range:821-870
MW: 135 kD
Format: Antiserum

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-MN1"
Write a review
or to review a product.
Viewed